Drugmaker
“Legislators were forced to make the difficult policy choice—that in an emergency, the national interest is best served by the rapid development and deployment of life-saving vaccines without the looming threat of litigation,” Robert Reeves Anderson, an Arnold & Porter Kaye Scholer partner representing AstraZeneca, argued Wednesday before US Court of Appeals for the Tenth Circuit judges.
Brianne Dressen sued ...
